Fast and reliable in vitro diagnostic test for detection of Influenza A and B antigens. Provides rapid results to support clinical diagnosis and treatment decisions for respiratory infections.
Manufactured by
Taiwan
Panion & BF Biotech Inc. is a Taiwan publicly listed biotech and pharmaceutical company founded in 1976 with over 50 years of involvement in pharmaceutical and new drug research and development. VStrip, developed by PBF in 2014, specializes in rapid antigen tests for respiratory viruses including influenza, COVID-19, and RSV. VStrip products are globally certified and trusted for speed, accuracy, ease of use, and reliable public health and clinical support.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Innovation Biotech (Beijing) Co., Ltd
China · 1 relevant product
Soluções em Diagnóstico e Biotecnologia
Brazil · 1 relevant product
Boston Easy Biotech Inc.
United States · 2 relevant products
68 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →16 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 102 closest product alternatives
Innovation Biotech (Beijing) Co., Ltd · China
A rapid test strip kit for detecting influenza A and B viruses in respiratory samples. This diagnostic kit enables quick identification of influenza virus infection in clinical and point-of-care settings.
Soluções em Diagnóstico e Biotecnologia · Brazil
Rapid immunochromatographic test for simultaneous detection of Influenza A and B viruses from respiratory specimens. Delivers results in approximately 10-15 minutes, enabling quick clinical decision-making and appropriate patient management in point-of-care and laboratory settings.
Boston Easy Biotech Inc. · United States
FDA-cleared rapid antigen test for simultaneous detection of Influenza A and B. Designed for clinical and point-of-care settings, this test delivers fast, reliable results to support timely diagnosis and patient management. Suitable for respiratory screening in healthcare facilities and retail pharmacy channels.
99 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products